In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
LM_ID | Common Name | Systematic Name | Formula | Mass |
---|---|---|---|---|
LMFA04010204 | ent-16-epi-13-D4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010205 | ent-16-epi-13-D4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010206 | ent-13-D4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010207 | 13-epi-13-D4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010208 | 13,16-diepi-13-D4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010209 | 13,16-diepi-13-D4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010210 | 13-epi-13-D4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010211 | ent-13-epi-13-D4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010212 | ent-13,16-diepi-13-D4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010213 | ent-13,16-diepi-13-D4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010214 | ent-13-epi-13-D4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010215 | 13-D4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010216 | 16-epi-13-D4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010217 | 16-epi-13-D4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010218 | 13-D4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,5S)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010219 | ent-14-D4t-NeuroP | (Z)-6-((1R,2S,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010220 | ent-7-epi-14-D4c-NeuroP | (Z)-6-((1R,2R,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010221 | ent-7-epi-14-D4t-NeuroP | (Z)-6-((1S,2S,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010222 | ent-14-D4c-NeuroP | (Z)-6-((1S,2R,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010223 | ent-14-epi-14-D4t-NeuroP | (Z)-6-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010224 | ent-7,14-diepi-14-D4c-NeuroP | (Z)-6-((1R,2R,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010225 | ent-7,14-diepi-14-D4t-NeuroP | (Z)-6-((1S,2S,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010226 | ent-14-epi-14-D4t-NeuroP | (Z)-6-((1S,2R,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010227 | 14-epi-14-D4c-NeuroP | (Z)-6-((1R,2S,5S)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010228 | 7,14-diepi-14-D4t-NeuroP | (Z)-6-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010229 | 7,14-diepi-14-D4c-NeuroP | (Z)-6-((1S,2S,5S)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010230 | 14-epi-14-D4t-NeuroP | (Z)-6-((1S,2R,5S)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010231 | 14-D4c-NeuroP | (Z)-6-((1R,2S,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010232 | 7-epi-14-D4t-NeuroP | (Z)-6-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010233 | 7-epi-14-D4c-NeuroP | (Z)-6-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010234 | 14-D4t-NeuroP | (Z)-6-((1S,2R,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010235 | ent-17-D4t-NeuroP | (4Z,7Z)-9-((1R,2S,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010236 | ent-10-epi-17-D4c-NeuroP | (4Z,7Z)-9-((1R,2R,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010237 | ent-10-epi-17-D4t-NeuroP | (4Z,7Z)-9-((1S,2S,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010238 | ent-17-D4c-NeuroP | (4Z,7Z)-9-((1S,2R,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010239 | ent-17-epi-17-D4t-NeuroP | (4Z,7Z)-9-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010240 | ent-10,17-diepi-17-D4c-NeuroP | (4Z,7Z)-9-((1R,2R,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010241 | ent-10,17-diepi-17-D4t-NeuroP | (4Z,7Z)-9-((1S,2S,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010242 | ent-17-epi-17-D4t-NeuroP | (4Z,7Z)-9-((1S,2R,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010243 | 17-epi-17-D4c-NeuroP | (4Z,7Z)-9-((1R,2S,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010244 | 10,17-diepi-17-D4t-NeuroP | (4Z,7Z)-9-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010245 | 10,17-diepi-17-D4c-NeuroP | (4Z,7Z)-9-((1S,2S,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010246 | 17-epi-17-D4t-NeuroP | (4Z,7Z)-9-((1S,2R,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010247 | 17-D4c-NeuroP | (4Z,7Z)-9-((1R,2S,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010248 | 10-epi-17-D4t-NeuroP | (4Z,7Z)-9-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010249 | 10-epi-17-D4c-NeuroP | (4Z,7Z)-9-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010250 | 17-D4t-NeuroP | (4Z,7Z)-9-((1S,2R,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010251 | ent-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010252 | ent-13-epi-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010253 | ent-13-epi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |